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1078–5884/00A Preliminary Study on the Effects of Exercising to Maximum
Walking Distance on Platelet and Endothelial
Function in Patients with Intermittent Claudication
P. Collins,1 I. Ford,2 D. Ball,1 E. Macaulay,2 M. Greaves2 and J. Brittenden*,31Department of Vascular Surgery, Aberdeen Royal Infirmary, 2Department of Medicine & Therapentics,
University of Aberdeen, 3Department of Vascular Surgery, University of Aberdeen, Aberdeen, Scotland, UKBackground. Platelet and endothelial activation has been shown to be increased in patients with intermittent claudication
(IC). Recent studies have suggested that exercise may induce further platelet activation. The aims of this study were to
investigate the effect of exercising to maximum walking distance on platelet and endothelial function in patients with
intermittent claudication who were receiving statin and aspirin therapy compared with age matched healthy controls.
Methods. Platelet aggregation through COX-mediated and thrombin receptor activator peptide (TRAP)-stimulated
GPIIb/IIIa pathways was measured by the Ultegra point of care system in 20 patients with IC on aspirin and 20 healthy
volunteers before, immediately and 1 h after exercising to treadmill maximal walking distance (MWD). Soluble P-selectin,
vWF and sICAM were measured using an enzyme linked immuno-sorbent assay technique.
Results. Baseline platelet aggregation was significantly reduced in patients with IC compared to volunteers (p!0.05). In
patients, exercising to MWD significantly reduced platelet aggregation (COX, median K5% [range K24 to 13%]; pZ
0.02; GPIIIa/IIb, median K13% [range K72 to 33%]; pZ0.02) immediately post-exercise which returned to baseline values
at 1 h. There was no change in the healthy volunteers following the same median duration of exercise. Baseline sP-selectin
levels were higher in the patients with IC compared to the healthy volunteers [Median values (interquartile range), 42.72
(33.28–54.24) versus 29.16 (24.40–34.10), pZ0.0003] but there were no differences in vWF levels. Both sP-selectin and
vWF levels increased significantly in the control and patient group following exercise (p!0.005). sICAM were higher at
baseline in the patients with IC but were unchanged following exercise [Median values (interquartile range),560.9 (405.5–
739.4) versus 467.0 (325.7–643.4), p!0.05].
Conclusion. This study is the first to show that platelet aggregation is reduced immediately following treadmill exercise to
maximum walking distance in patients with IC despite a rise in sP-selectin and vWF, suggesting endothelial activation. The
inhibition of platelet aggregation after exercise in subjects on antiplatelet and statin therapy suggests that exercise is unlikely
to exacerbate platelet thrombus formation in patients with IC.Keywords: Platelet aggregation; Soluble P-selectin; sICAM; von Willebrand factor, exercise, intermittent claudication.Introduction
Supervised exercise therapy has been shown to
improve walking distances and improve quality of
life in patients with intermittent claudication (IC).1
However, despite these proven benefits of exercise
therapy, recent evidence suggests that exercise in
patients with IC may induce a systemic inflammatory
response.2–4 There is concern that exercise is associated
with an ischaemia-reperfusion type injury with the
release of oxygen free radicals, neutrophil activation
and the release of pro-inflammatory eicosanoids.2,3 Toing author. Dr J. Brittenden, C/O Aberdeen Royal
rd 36, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK.
: j.brittenden@arh.grampian.scot.nhs.uk
0266 + 08 $35.00/0 q 2006 Elsevier Ltd. All rights reserdate, few studies have investigated the effect of
exercise on platelet function in patients with IC
Platelets, through their interaction with the vascular
endothelium and their role in thrombus formation,
have been implicated in the development and
progression of atherosclerosis and in the pathogenesis
of acute ischaemic events.4 Recent studies have shown
that platelet activation is increased in patients with
peripheral arterial disease (PAD) despite the use of
aspirin.5–8
The effects of exercise on platelet function have
been assessed mainly by measurement of sP-selectin, a
marker of platelet activation in four previous studies.
Exercising on a treadmill to maximum walking
distance (MWD) is associated with either no changeEur J Vasc Endovasc Surg 31, 266–273 (2006)
doi:10.1016/j.ejvs.2005.10.011, available online at http://www.sciencedirect.com onved.
Table 1. Demographics of patient with IC and volunteer
Volunteers (nZ20) Patients with IC
Platelet and Endothelial Function Following Exercise 267or an increase in sP-selectin immediately following
exercise.9–12 P-selectin is a protein found in the alpha
granules of resting platelets and the Weibel–Palade
bodies of endothelial cells.13 On activation, P-selectin
is expressed on the cell surface and then released into
the circulation. It is thus a marker of both platelet and
endothelial activation.13 More specific and well
validated measures of platelet activation include
flow cytometry and platelet aggregation.14 To date,
two studies have assessed the effect of exercise on
platelet function using flow cytometry in patients with
intermittent claudication. These have shown an
increase in platelet surface markers of activation
such as P-selectin and GPIIb/IIIa.15,16 To the best of
our knowledge the effect of exercise on platelet
aggregation in patients with IC has not previously
been reported. Flow cytometry and aggregation
assess different aspects of platelet function and a
lack of correlation has been described in patients
with intermittent claudication, aortic aneurysms and
carotid disease.6
Platelet adhesion to the vascular endothelium is
mediated by von Willebrand factor (vWF),17 which
also serves as a marker of endothelial function. VWF
levels have been shown to be increased in patients
with intermittent claudication, but the effect of
exercise is unclear with some studies showing an
increase.12,18 and others no change following exercise
to maximum walking distance.19,20 Soluble intercel-
lular adhesion molecules such as sICAM-1, also serve
as a marker of endothelial and platelet function and
are known to be elevated in patients with IC and those
at risk of developing PAD.21 Exercising to maximum
walking distance has been shown to increase levels of
sICAM-1 in patients with IC.12,22
We hypothesised, that in patients with IC who were
already receiving appropriate secondary prevention
including aspirin and a statin that the apparent
exercise induced platelet activation would be attenu-
ated. The aims of this study were to investigate the
effects of treadmill exercise on platelet and endothelial
function in patients with intermittent claudication and
healthy controls as assessed by platelet aggregation,
soluble plasma P-selectin, von-Willebrand factor
(vWF) and sICAM-1.(nZ20)
Male:Female 11:9 16:4
Mean age (SD) 63 (10) 68 (8) *
Mean ABPI (SD) 1.14 (0.10) 0.62 (0.13)
Smokers
Never 13 1
Reformed 5 12
Current 2 7
Aspirin therapy 0 20
Numbers represent means with standard deviations in brackets.
* pZ0.072, unpaired t-test.Patients and Methods
The study population consisted of 20 patients with
intermittent claudication on best medical therapy and
20 healthy controls. The study was approved by the
local research ethics committee and written consent
was obtained. Patients were required to have adiagnosis of chronic, stable intermittent claudication
for at least 6 months and an ankle brachial pressure
index (ABPI) of less than or equal to 0.8. All patients
were on secondary prevention therapy which
included 75 mg of aspirin and statin therapy of at
least 6 weeks duration. Statin therapy consisted of
40 mg of simvastatin or pravastatin and 10 mg of
atorvastin, depending on individual General prac-
titioners prescribing practice. Patients on clopidogrel,
anti-inflamatory therapy, cilostazol or praxilene were
excluded as were patients with diabetes. Patients who
were judged unable to exercise due to other co-existing
morbidities were excluded. The healthy age-matched
volunteers were recruited from the surgical out-
patient clinics. The presence of cardiovascular disease
was excluded by medical questionnaire and physical
examination including ABPIs. All volunteers had an
ABPI greater than or equal to one. No control subject
was taking anti-platelet, statin or non-steroidal
therapy for at least 14 days prior to testing. The
demographic details for the patient and volunteer
group are shown in Table 1.Treadmill exercise
Patients with IC walked on a treadmill (speed
3.5 km/h, incline 5 8) to their maximum walking
distance. Exercise duration, time to onset and resol-
ution of typical calf pain was recorded for all patients.
Healthy controls walked for 3 min and 20 s which
corresponded to the average patient exercise duration
and represented a walking distance of 194 m.Blood sampling and processing
Patients and volunteers attended for exercise after 9
am fasted for at least 6 h having abstained from
unaccustomed physical activity for the preceding 24 h.
All subjects were rested for 30 min in a supine position
prior to initial blood sampling. An 18 G cannula wasEur J Vasc Endovasc Surg Vol 31, 3 2006
P. Collins et al.268inserted into a large vein in the ante-cubital fossa.
Patency was maintained by flushing the cannula with
5 ml boluses of 0.9% normal saline between sampling.
All blood samples were collected using a ‘double
syringe’ technique and without the use of a tourniquet.
The first 10 ml of blood collected was discarded.
Citrated blood for platelet aggregation was assayed
within 15 min of blood drawing. Blood for soluble
P-selectin, vWF and sICAM-1were centrifuged (4 8C at
2500 G) and the plasma separated, snap-frozen in
liquid nitrogen and stored at K80 8C for future
analysis. Subsequent blood samples were collected
immediately after the cessation of exercise and
following a period of one hour of rest.
Platelet aggregation
Platelet aggregation was assessed using the Ultegra
Rapid Platelet Function Analyser (Accumetrics, San
Diego, CA). This is a well validated, fully automated,
point of care, whole blood cartridge based turbidi-
metric optical detection system which assesses the
ability of activated platelets to bind fibrinogen
coated micro-beads contained within the cartridge
test wells.23,24 Fibrinogen-coated microparticles
agglutinate in whole blood in proportion to the number
of available GPIIb/IIIa receptors, causing an increase in
light transmittance. It has been shown to correlate well
with conventional platelet aggregometry.25 The agonist
in the RPFA-TRAP assay is thrombin-receptor activat-
ing peptide (TRAP) and in the RPFA-ASA assay consist
of a metallic cation and propyl gallate which specifi-
cally act on the cyclo-oxygenase (COX) pathway. The
analyser measures the change in the optical signal and
reports it as platelet aggregation units (PAU) for the
RPFA-TRAP assay and aspirin reaction units (ARU) for
the RPFA-ASA. Both TRAP-stimulated and COX-
mediated platelet aggregation were measured at all
three timepoints. All assays were performed by the
same individual. Our laboratory inter-assay variation
was 5.8% for RPFA-ASA and 5.0% for RPFA-TRAP.
Plasma soluble (s) P-selectin
sP-selectin was assayed using a commercially avail-
able enzyme linked immuno-sorbent assay technique
(R&D Systems, Inc., Minneapolis, USA). All samples
were assayed in duplicate, the mean value was
calculated and all patient samples were analysed on
the same run. Intra-assay coefficient of variation in our
laboratory was 4.3%.
Plasma vonWillebrand factor (vWF)
vWF was assayed using an in-house enzyme linked
immuno-sorbent assay technique. All samples were
assayed in duplicate, the mean value was calculatedEur J Vasc Endovasc Surg Vol 31, 3 2006and all patient samples were analysed on the same
run. Intra-assay coefficient of variation in our labora-
tory was 2.7%.
Soluble cellular adhesion molecule-1 (sICAM)
S-ICAM was measured by sandwich ELISA (R&D
Systems, Inc., Minneapolis, USA). All samples were
assayed in duplicate, the mean value was calculated
and all patient samples were analysed on the same
run. Intra-assay coefficient of variation in our labora-
tory was 2.7%.Statistical analysis
All statistical analysis was performed using SPSS
Version 11.5 for windows. Age data was normally
distributed. The remainder of the data was non-
parametrically distributed. Initial analysis was via
Friedman’s test (one-factor within subjects). Between
time-point comparisons were performed using the
Wilcoxon signed-rank test. Thus, for each patient the
post-exercise values were compared to their original
baseline values and, therefore, each patient served as
their own control. We acknowledge that there are a
large number of possible confounding variables,
which could influence an individual patients response
to exercise. However, it was felt that subgroup analysis
of a patient cohort of 20 would be inappropriate. The
difference in baseline measurements between groups
was tested using the Mann–Whitney U-test. Chi-
squared test was used to measure variation in
demographic parameters between the groups. Expert
statistical advice was sought from the Department of
Statistics, University of Aberdeen.ResultsPlatelet aggregation
Baseline COX-mediated aggregation was significantly
lower in the patients with IC compared to the healthy
volunteers [Median values (interquartile range), 514
(341–667) versus 573 (343–751), pZ0.002]. Similarly
baseline TRAP-stimulated aggregation was signifi-
cantly lower in the patients with IC compared to the
healthy volunteers [Median values (interquartile
range), 185 (120–232) versus 215 (111–313), pZ0Z
0.005]. On the treadmill, the mean maximal walking
time of the patients was 3 min 20 s (SD 130 s) which
corresponded to a mean distance of 194 m (SD 12 m).
Exercise to maximum walking distance in the patients
with IC resulted in a significant fall in both
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Fig. 1. COX-Mediated platelet aggregation following tread-
mill exercise in patients with IC. Timepoint (A) baseline, (B)
immediately post-exercise, (C) after 1 h of rest. Data
presented as box-plots-line in centre of box represents the
median value; the box represents the inter-quartile range and
the whiskers represent the range. Friedman test: pZ0.026,
p!0.005 Wilcoxon signed rank test at time B compared to
baseline [0 h].
Platelet and Endothelial Function Following Exercise 269COX-mediated and TRAP-stimulated aggregation
immediately post exercise (Figs. 1 and 2, p!0.005,
one way Friedman’s test). Median percentage change
was K13% (range K72 to 33% [pZ0.02, Wilcoxon rank
test]) for TRAP-stimulated and K5% (range K24 to
13% [pZ0.005, Wilcoxon rank test]) for COX-mediated
aggregation. There was no change in platelet aggrega-
tion following exercise in the volunteer group (Figs. 3
and 4). None of the healthy volunteers complained of
lower limb pain during the exercise.TIMEPOINT
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Fig. 2. TRAP-Stimulated platelet aggregation following
treadmill exercise in patients with IC. Time point (A)
baseline, (B) immediately post-exercise, (C) after 1 h of rest.
Data presented as box-plots-line in centre of box represents
the median value; the box represents the inter-quartile range
and the whiskers represent the range. Friedman test:
pZ0.002, p!0.02 Wilcoxon signed rank test at time B
compared to baseline [0 h].Plasma sP-selectin
Baseline sP-selectin levels were higher in the patients
with IC compared to the healthy volunteers [Median
values (interquartile range), 42.72 (33.28–54.24) versus
29.16 (24.40–34.10), pZ0.003]. sP-selectin levels
increased significantly in both groups following
exercise (Table 2).Plasma vWF
There was no difference in baseline vWF levels
between patients with IC and volunteers [Median
values (interquartile range), 169.95 (131.44–192.74)
versus 135.42 (119.82–175.20), pO0.05]. vWF levels
increased significantly in both groups following
exercise. The magnitude of the change was greatest
in the healthy volunteers (Table 2).sICAM-1
Baseline sICAM-1 levels were higher in the patients
with IC compared to the healthy volunteers [Median
values (interquartile range), 560.9 (405.5–739.4) versus
467.0 (325.7–643.4), p!0.05]. sICAM-1 levels were
unchanged following exercise in both groups (Table 2).Discussion
To the best of our knowledge, this is the first study to
investigate the effect of acute exercise on platelet
aggregation in patients with IC. The patients were on
secondary prevention therapy, which included a statin
and aspirin both of which are known to reduce platelet
aggregation.26,27 This resulted in a lower baseline
aggregation in the patients compared to the controls
for both GPIIb/IIIa pathway TRAP-stimulated and
COX-mediated platelet aggregation. This is reassuring,
given the fact that a number of studies have shown that
platelet activation as assessed by flow cytometry is
increased in patients with IC despite aspirin and statin
therapy.5 A previous study had shown a higher rate of
spontaneous and collagen induced platelet aggregation
in patients with PAD compared to healthy controls
despite the use of aspirin.6 This study, however,
included a mixture of patients with IC and rest pain
and it is unclear if the patients were on statin therapy in
addition to aspirin. In this and other studies a large
variation has been shown to exist in platelet function in
both patients with IC and healthy volunteers.5–8 A
value of less than 550 aspirin reaction units with the
ultegra RPFA-ASA has been shown to correlate withEur J Vasc Endovasc Surg Vol 31, 3 2006
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Fig. 3. COX-Mediated platelet aggregation following tread-
mill exercise in healthy volunteers. Timepoint (A) baseline,
(B) immediately post-exercise, (C) after 1 h of rest. Data
presented as box-plots-line in centre of box represents the
median value; the box represents the inter-quartile range and
the whiskers represent the range. Friedman’s test (One-
factor within subjects): pO0.05
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P. Collins et al.270platelet dysfunction consistent with aspirin use in
patients.28 In this small study, seven out of 20 patients
had a baseline ARU greater than 550 despite the use of
aspirin therapy. For TRAP stimulated platelet aggrega-
tion the normal values expected for patients are in the
range of 125–330 platelet aggregation units, which is
consistent with the findings in this study.23–25 However,
despite the lower baseline aggregation observed in the
patients with IC, exercising to maximum walking
distance resulted in a further significant fall in platelet
aggregation apparent immediately after exercising.
Thus, the inhibition of platelet aggregation afterTIMEPOINT
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Fig. 4. TRAP-Stimulated platelet aggregation following
treadmill exercise in healthy volunteers. Timepoint (A)
baseline, (B) immediately post-exercise, (C) after 1 h of rest.
Data presented as box-plots-line in centre of box represents
the median value; the box represents the inter-quartile range
and the whiskers represent the range. Friedman’s test (One-
factor within subjects): pO0.05 Ta
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Platelet and Endothelial Function Following Exercise 271exercise in subjects on antiplatelet and statin therapy
suggests that exercise is unlikely to exacerbate platelet
thrombus formation in patients with IC.
In healthy volunteers the effect of exercise on platelet
function has been shown to vary depending on
the intensity of exercise and the subjects’ fitness.29
Strenuous physical exercise has been shown to activate
platelets in sedentary but not in physically active
subjects, yet moderate exercise has an inhibitory effect
on platelet aggregation. The lack of a fall in platelet
aggregation in the volunteer group following treadmill
exercise is likely to reflect the fact that the exercise
intensity was minimal. The duration of treadmill
exercise in the volunteer group was limited to allow
direct comparison with the patients with IC. Thus, the
inclusion of healthy controls in this study clearly
demonstrates that exercise alone did not affect platelet
function, but exercising to the point of muscle pain
induced by ischaemia did reduce platelet activation.
The observed effects on platelet function in patients
with IC may be mediated through a catecholamine and
haemodynamic response to exercise. It could be
postulated that exercise induced epinephrine release
and the effect of shear forces on the endothelium result
in an increased vWF levels and nitric oxide pro-
duction.30–33 Platelet aggregation is attenuated by nitric
oxide which is one possible explanation for the reduced
aggregation noted in this study.30 The effect of aspirin
and statin on nitric oxide production after exercise is
not known. While it would have been desirable to have
assessed the effect of exercise on platelet aggregation in
patients with IC who are not on these medications this
would be difficult to achieve and indeed unethical. It
would also not be relevant to current accepted practice
of the management of patients with IC.
In the current study we did not assess other
measures of platelet activation such as flow cytometry.
Two studies to date have used flow cytometry and
both have shown exercise induced platelet activation
with increased expression of surface markers includ-
ing P-selectin.15,16 However, while the results of these
two studies may appear at odds with the results of
this study, it should be noted that previous studies in
patients with PAD have shown a lack of correlation
between platelet aggregation and flow cytometry
detected platelet activation.6 Pasupathy et al., also
demonstrated an increase in platelet-leucocyte inter-
action and platelet-leucocyte aggregation immediately
after exercise in patients with claudication.15 This was
attenuated by a warm up phase allowing ischaemic
pre-conditioning. This observed increase in platelet-
leucocyte interactions could reflect leucocyte stimu-
lation by exercise rather than indicating a role for
platelets in exercise-induced inflammation.It could be postulated that the reduction in platelet
aggregation in vitro is due to the platelets becoming
activated and degranulated in vivo and thus less
responsive to subsequent stimulation.34 However, we
have previously shown increased platelet aggregation
and reduced sP-selectin levels but increased surface
P-selectin expression immediately and 24 h after
surgery in patients with PAD undergoing lower limb
revascularisation which is a much more potent
stimulus.35 In the current study, there was also no
rise in sICAM-1 levels post exercise. Activated
platelets have been shown to increase the expression
of ICAM-1on endothelial cells in vitro.36,37 Thus, if the
platelets were activated we might expect to see a rise
in ICAM-1 following sequestration from the endo-
thelium into the plasma.
In this and other studies, sP-selectin levels were
found to be increased in patients with IC compared to
healthy controls.10 Following treadmill exercise there
was a further increase in sP-selectin levels in both
groups. This was also associated with a rise in vWF,
suggesting that this is an endothelial response rather
than a shedding from activated platelets. This is
supported by the recent study of McBane et al. who
found significantly lower levels of alpha-granule
P-selectin in platelets from patients with peripheral
arterial disease compared to controls.38 Furthermore,
P-selectin expression on endothelial cells is known to
occur within a minute of activation and is transient,
whereas platelet express P-selectin for at least an hour
before being shedding it into the circulation.39–41 The
previous studies which have examined the effect of
treadmill exercise on sP-selectin levels in patients with
IC have either shown no difference or an increase
immediately following exercise.9–12 The discrepancy
in results may in part be due to differing exercise
regimens, variation in sample timing and the fact that
not all subjects were rested prior to baseline blood
sampling. We ensured throughout this study that
patients and volunteers were rested prior to and
following the exercise regimen.42
In summary, this preliminary study is the first to
show that platelet aggregation is reduced immediately
following treadmill exercise in patients with IC. It has
also shown a rise in sP-selectin and vWF, suggesting
endothelial activation. Further, studies are required to
determine the effect of the medium and long term
effects of various exercise regimens including arm
exercise on platelet and endothelial function. Exercis-
ing to maximum walking distance appears to have a
potential beneficial effect on platelet function with a
reduction in aggregation in patients with IC who are
already receiving secondary prevention therapy. It is
unclear at this stage, if exercise in addition to so calledEur J Vasc Endovasc Surg Vol 31, 3 2006
P. Collins et al.272‘best medical therapy’ has the potential to reduce
thrombotic events in these patients. However, the
inhibition of platelet aggregation after exercise in
subjects on antiplatelet and statin therapy suggests
that exercise is unlikely to exacerbate platelet
thrombus formation in patients with IC.References
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